The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.
 
Stephanie Lheureux
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck; Roche/Genentech
Research Funding - AstraZeneca (Inst); Merck (Inst); Regeneron (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Daniela Matei
Honoraria - AstraZeneca; Genentech/Roche; Radius Health; Tesaro
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche/Genentech
Research Funding - Merck; Merck
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Radius Health
 
Panagiotis A. Konstantinopoulos
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Pfizer/EMD Serono; Tesaro; Vertex
Research Funding - AstraZeneca (Inst); Bayer (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Pfizer (Inst); tesaro (Inst)
 
Matthew Stephen Block
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Immune Design; Marker, Inc.; Merck; Pharmacyclics
 
Andrea Jewell
No Relationships to Disclose
 
Stephanie Gaillard
Consulting or Advisory Role - AstraZeneca; Immunogen; Rigel (Inst); Sermonix Pharmaceuticals
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Sermonix Pharmaceuticals
 
Michael S. McHale
No Relationships to Disclose
 
Carolyn K McCourt
Consulting or Advisory Role - Genentech
 
Sarah Temkin
No Relationships to Disclose
 
Eugenia Girda
No Relationships to Disclose
 
Floor Jenniskens Backes
Consulting or Advisory Role - Abbott Diagnostics (I); Agenus; AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; Merck; Tesaro
Research Funding - Clovis Oncology (Inst); Eisai (Inst); Immunogen (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate (for writing a chapter)
 
Theresa Louise Werner
Research Funding - AbbVie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); Genmab (Inst); Mersana (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tesaro (Inst)
 
Linda R. Duska
Consulting or Advisory Role - CUE Biopharma; Genentech/Roche; Inovio Pharmaceuticals; Merck; Morphotek; Tesaro
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Cerulean Pharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Leap Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Millennium (Inst); Morab (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst); Syndax (Inst); Tesaro (Inst)
 
Siobhan Marie Kehoe
No Relationships to Disclose
 
Lisa Wang
No Relationships to Disclose
 
Rachel Wildman
No Relationships to Disclose
 
Ben X Wang
No Relationships to Disclose
 
Pamela S Ohashi
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Gini F. Fleming
Honoraria - Curio Science
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Abbvie (Inst); Astex Pharmaceuticals (Inst); Compugen (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Forty Seven (Inst); Genentech (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Leap Therapeutics (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sermonix Pharmaceuticals (Inst); Syndax (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)
(OPTIONAL) Uncompensated Relationships - TTC Oncology